Gregory R. Friberg

Insider Reports History

Location
San Rafael, CA
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory R. Friberg:

Company Role Class Num Shares Value Price $ Report Date Ownership
BIOMARIN PHARMACEUTICAL INC EVP, Chief R&D Officer Common Stock 37,578 $2,268,801 $60.38 26 Feb 2026 Direct
BIOMARIN PHARMACEUTICAL INC EVP, Chief R&D Officer Stock Option (Right to Buy Common Stock) 41,170 17 Mar 2025 Direct

Insider Reports Filed by Gregory R. Friberg

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BMRN BIOMARIN PHARMACEUTICAL INC 26 Feb 2026 1 -$381,937 4 EVP, Chief R&D Officer 26 Feb 2026, 20:39
BMRN BIOMARIN PHARMACEUTICAL INC 31 Dec 2025 1 +$18,123 5 EVP, Chief R&D Officer 13 Feb 2026, 18:54
BMRN BIOMARIN PHARMACEUTICAL INC 30 Sep 2025 1 -$178,945 4 EVP, Chief R&D Officer 02 Oct 2025, 16:33
BMRN BIOMARIN PHARMACEUTICAL INC 17 Mar 2025 2 $0 4 EVP, Chief R&D Officer 18 Mar 2025, 18:23
BMRN BIOMARIN PHARMACEUTICAL INC 30 Sep 2024 3 $0 4 EVP, Chief R&D Officer 01 Oct 2024, 16:51
BMRN BIOMARIN PHARMACEUTICAL INC 30 Sep 2024 0 $0 3 EVP, Chief R&D Officer 01 Oct 2024, 16:50